Diagnostic Role of Prostate Resection in the Elderly Patients Who Experience Significant Co-Morbidity with a High Clinical Suspicion of Prostate Cancer

Abstract

The necessity of routine prostate biopsy prior to transurethral resection of the prostate (TURP) in elderly comorbid patients with a high prostate specific antigen (PSA) level remains controversial. We assessed the role of TURP in prostate cancer diagnosis in these individuals. A total of 197 patients underwent TURP in conjunction with prostatic needle biopsy. Pathologic reviews of specimens of TUR chips and biopsy cores were analyzed. Overall, prostate cancer (CaP) was detected in 114 patients (57.6%). Ninety-eight cancers (86%) were detected with TURP and biopsy, and seven cancers (6.1%) with only TURP. The Gleason score of a TUR-specimen was identical to that of the biopsy-core in 43.9% of cases. Variables associated with diagnostic accuracy in the TUR-specimens included the prebiopsy PSA level, prostate specific antigen density (PSAD), and the Gleason score in biopsy cores. In patients with a PSA level and a PSAD that was greater than 15.4 ng/mL and 0.69 ng/mL/g, respectively, 100% of the cancers were detected in the TUR-specimens. Our results suggest that a prostatic biopsy might be omitted prior to TURP in elderly patients with significant co-morbidity and levels for PSA of >15.4 ng/mL.

Transurethral Resection in Prostate Cancer

“…Kang ve ark. 'nın yaptığı başka bir çalışmada, ortalama PSA değeri bir önceki çalışmadan çok daha yüksek (51.77 ng/ml) olan prostat kanserli hastaların %92.1'ine TURP ile tanı konulabildiğini bildirilmiştir [32]. Ek olarak diğer çalışmalarda daha önce alınan biyopsileri negatif olan ve PSA değerleri yükselmeye devam eden hastalarda da TURP'nin prostat karsinomu tanısı koymada değerli bir araç olduğu bildirilmiştir [33][34].…”